Human cannabinoid pharmacokinetics

被引:787
作者
Huestis, Marilyn A. [1 ]
机构
[1] Natl Inst Drug Abuse, NIH, Intramural Res Program, Baltimore, MD 21146 USA
关键词
D O I
10.1002/cbdv.200790152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:1770 / 1804
页数:35
相关论文
共 189 条
[41]   EXCRETION PATTERNS OF CANNABINOID METABOLITES AFTER LAST USE IN A GROUP OF CHRONIC USERS [J].
ELLIS, GM ;
MANN, MA ;
JUDSON, BA ;
SCHRAMM, NT ;
TASHCHIAN, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :572-578
[42]  
ElSohly MA, 2000, J FORENSIC SCI, V45, P24
[43]   Simultaneous analysis of Δ9-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure [J].
Feng, SX ;
ElSohly, MA ;
Salamone, S ;
Salem, MY .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2000, 24 (06) :395-402
[44]  
FOLTZ RL, 1984, ADV ANAL TOXICOLOGY, P125
[45]   Urinary excretion protiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and 11-hydroxy-Δ9-THC:: cannabinoid metabolites to creatinine ratio study IV [J].
Fraser, AD ;
Worth, D .
FORENSIC SCIENCE INTERNATIONAL, 2004, 143 (2-3) :147-152
[46]   Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol Study III.: A Δ9-THC-COOH to creatinine ratio study [J].
Fraser, AD ;
Worth, D .
FORENSIC SCIENCE INTERNATIONAL, 2003, 137 (2-3) :196-202
[47]   Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: A cannabinoid-to-creatinine ratio study [J].
Fraser, AD ;
Worth, D .
THERAPEUTIC DRUG MONITORING, 2002, 24 (06) :746-750
[48]  
Garrett E R, 1978, Adv Biosci, V22-23, P105
[49]   PHARMACOKINETICS OF DELTA-9-TETRAHYDROCANNABINOL IN DOGS [J].
GARRETT, ER ;
HUNT, CA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) :395-407
[50]   PHYSICOCHEMICAL PROPERTIES, SOLUBILITY, AND PROTEIN-BINDING OF DELTA-9-TETRAHYDROCANNABINOL [J].
GARRETT, ER ;
HUNT, CA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (07) :1056-1064